Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2012 1
2018 1
2019 1
2020 3
2021 3
2022 4
2023 3
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for lalovic author
Your search for lalovic aAuthor retrieved no results
Co-design of dementia prevention program for Aboriginal Australians (DAMPAA).
Mateo-Arriero I, Lalovic A, Dowden G, Markey L, Cox KL, Flicker L, Bessarab D, Thompson S, Kickett C, Woods D, Pestell CF, Edgill P, Etherton-Beer C, Smith K. Mateo-Arriero I, et al. Alzheimers Dement. 2023 Oct;19(10):4564-4571. doi: 10.1002/alz.13032. Epub 2023 Mar 18. Alzheimers Dement. 2023. PMID: 36933191 Free PMC article.
Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease.
Majid O, Cao Y, Willis BA, Hayato S, Takenaka O, Lalovic B, Sreerama Reddy SH, Penner N, Reyderman L, Yasuda S, Hussein Z. Majid O, et al. CPT Pharmacometrics Syst Pharmacol. 2024 Dec;13(12):2111-2123. doi: 10.1002/psp4.13224. Epub 2024 Aug 29. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39207112 Free PMC article.
Lecanemab (Leqembi) was recently approved by health authorities in the United States, Japan, and China to treat early Alzheimer's disease (AD), including patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease upon confirmation of amyloid …
Lecanemab (Leqembi) was recently approved by health authorities in the United States, Japan, and China to treat early Alzheimer's dis …
26 results